Browse by Warwick Author
|Up a level|
Number of items: 11.
Ainsworth, N. L., Marshall, A. (Andrea), Hatcher, H., Whitehead, L., Whitfield, G. A. and Earl, H. M.. (2012) Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients. Annals of Oncology, Volume 23 (Number 7). pp. 1845-1853. ISSN 0923-7534
Rughani, M. G., Swan, M. C., Adams, T. S., Marshall, A. (Andrea), Asher, R., Cassell, O. C. and Middleton, M. (Mark). (2012) Sentinel node status predicts survival in thick melanomas : the Oxford perspective. European Journal of Surgical Oncology (EJSO), Vol.38 (No.10). pp. 936-942. ISSN 0748-7983
Marshall, A. (Andrea), Dunn, Janet A., Fletcher, Julie, Higgins, Helen B. and Poole, Christopher (2011) The importance of planning for a seamless transition in an adaptive phase II randomised trial. Trials, Vol.12 (Suppl.1). A7. ISSN 1745-6215
Marshall, A. (Andrea), Altman, Douglas G., Royston, Patrick and Holder, Roger L.. (2010) Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Medical Research Methodology, Vol.10 (Article 7). ISSN 1471-2288
Cheah, N. L. C., Lupton, S., Marshall, A. (Andrea), Hartley, A. and Glaholm, J.. (2009) Outcome of T1N0M0 squamous cell carcinoma of the larynx treated with short-course radiotherapy to a total dose of 50 Gy in 16 fractions: the Birmingham experience. Clinical Oncology, Vol.21 (No.6). pp. 494-501. ISSN 0936-6555
Marshall, A. (Andrea), Altman, Douglas G., Holder, Roger L. and Royston, Patrick. (2009) Combining estimates of interest in prognostic modelling studies after multiple imputation: current practice and guidelines. BMC Medical Research Methodology, Vol.9 (Articl). ISSN 1471-2288
Marshall, A. (Andrea), Billingham, Lucinda J. and Bryan, Stirling. (2009) Can we afford to ignore missing data in cost-effectiveness analyses? European Journal of Health Economics, Vol.10 (No.1). pp. 1-3. ISSN 1618-7598
Biswas, S., Wrigley, J., East, C., Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, P., Middleton, M. (Mark) and Corrie, P.. (2008) A randomised trial evaluating Bevacizumab as adjuvant therapy following resection of AJCC stage IIB, IIC and III cutaneous melanoma : an update. ecancermedicalscience, Vol.2 . p. 108. ISSN 1754-6605
Biswas, S., East, C., A'Hern, A., Marshall, A. (Andrea), Dunn, Janet A., Lorigan, Paul, Middleton, M. (Mark) and Corrie, P. (2008) Adjuvant bevacizumab is safe treatment for melanoma patients at high risk of recurrence. In: 33rd European Society for Medical Oncology Congress, Stockholm, Sweden, 12-16 Sept 2008. Published in: Annals of Oncology, Vol.19 (Suppl.8). pp. 245-246.
Gray, R. G., Rea, D. W., Handley, K., Marshall, A. (Andrea), Pritchard, M. G., Perry, P., Earl, H. M., Poole, Christopher, Salman, A. and Lee, M. (2008) aTTom (adjuvant Tamoxifen--To offer more?) : randomized trial of 10 versus 5 years of adjuvant tamoxifen among 6,934 women with estrogen receptor-positive (ER+) or ER untested breast cancer--Preliminary results. In: 2008 ASCO Annual Meeting, Chicago, Illinois, 30 May-3 Jun 2008. Published in: Journal of Clinical Oncology, Vol.26 (No.15S (May 20 Supplement)). p. 513.
Burton, Andrea, Billingham, Lucina Jane and Bryan, Stirling. (2007) Cost-effectiveness in clinical trials : using multiple imputation to deal with incomplete cost data. Clinical Trials, Vol.4 (No.2). pp. 154-161. ISSN 1740-7745
This list was generated on Wed Jun 19 19:47:26 2013 BST.